Intravenous methylprednisolone in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) Metilprednisolona endovenosa na mielopatia associada ao HTLV-I/Paraparesia Espástica Tropical (MAH/PET)
HTLV-I (Human T-lymphotropic virus type I) associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an immunomediated myelopathy induced by the HTLV-I. Some patients, specially those from Japan, seem to have a good response to steroid treatment. However, this has not been found in other regio...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Thieme Revinter Publicações
1993-09-01
|
| Series: | Arquivos de Neuro-Psiquiatria |
| Subjects: | |
| Online Access: | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X1993000300005 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850214962460360704 |
|---|---|
| author | Abelardo Q-C Araújo Cristiane R. Afonso Ana Claudia B. Leite Solange V. Dultra |
| author_facet | Abelardo Q-C Araújo Cristiane R. Afonso Ana Claudia B. Leite Solange V. Dultra |
| author_sort | Abelardo Q-C Araújo |
| collection | DOAJ |
| description | HTLV-I (Human T-lymphotropic virus type I) associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an immunomediated myelopathy induced by the HTLV-I. Some patients, specially those from Japan, seem to have a good response to steroid treatment. However, this has not been found in other regions of the world. High dose intravenous methylprednisolone has been used with success in patients with relapses of multiple sclerosis (MS), another autoimmune disease of the central nervous system. To test the effectiveness of methylprednisolone in patients with HAM/TSP, we devised an open trial in 23 patients. We found a very limited benefit of this form of treatment in these patients. Only one patient, who had the shortest disease duration (five months) in the whole group, showed a sustained benefit. We speculate that those patients with a shorter history, with presumably less demye-lination and more inflammatory lesions, would show a better response to immunossupressive treatments.<br>A mielopatia associada ao protovírus T-linfotrópico humano (HTLV-I), também conhecida como paraparesia espástica tropical associada ao HTLV-I (MAH/PET), constitui enfermidade imunomediada desencadeada pela infecção pelo HTLV-I. Nesta condição tem sido demonstrada, particularmente em pacientes japoneses, boa resposta clínica à terapêutica com corticosteróides. Este efeito benéfico todavia não foi encontrado em todas as regiões do mundo. Pulsoterapia com metilprednisolona endovenosa tem sido utilizada com sucesso em pacientes com esclerose múltipla, outro exemplo de doença auto-imune do sistema nervoso central, especialmente durante as fases de exacerbação da doença. Objetivando testar a eficácia da pulsoterapia com metilprednisolona em pacientes com MAH/PET, conduzimos estudo aberto em 23 doentes. Não constatamos efeito benéfico significativo desta forma de tratamento na maioria dos enfermos estudados. Apenas um dos pacientes, o qual exibia o menor tempo de duração de doença (cinco meses), obteve benefício a longo prazo. Acreditamos que tratamentos imunossupressivos devam ser de maior utilidade naqueles doentes com menor tempo de evolução, nos quais, possivelmente, há preponderância do processo inflamatório sobre o desmielinizante. |
| format | Article |
| id | doaj-art-82ec04b645ad449eb31dc8a51b2f30cc |
| institution | OA Journals |
| issn | 0004-282X 1678-4227 |
| language | English |
| publishDate | 1993-09-01 |
| publisher | Thieme Revinter Publicações |
| record_format | Article |
| series | Arquivos de Neuro-Psiquiatria |
| spelling | doaj-art-82ec04b645ad449eb31dc8a51b2f30cc2025-08-20T02:08:46ZengThieme Revinter PublicaçõesArquivos de Neuro-Psiquiatria0004-282X1678-42271993-09-01513325328Intravenous methylprednisolone in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) Metilprednisolona endovenosa na mielopatia associada ao HTLV-I/Paraparesia Espástica Tropical (MAH/PET)Abelardo Q-C AraújoCristiane R. AfonsoAna Claudia B. LeiteSolange V. DultraHTLV-I (Human T-lymphotropic virus type I) associated myelopathy/tropical spastic paraparesis (HAM/TSP) is an immunomediated myelopathy induced by the HTLV-I. Some patients, specially those from Japan, seem to have a good response to steroid treatment. However, this has not been found in other regions of the world. High dose intravenous methylprednisolone has been used with success in patients with relapses of multiple sclerosis (MS), another autoimmune disease of the central nervous system. To test the effectiveness of methylprednisolone in patients with HAM/TSP, we devised an open trial in 23 patients. We found a very limited benefit of this form of treatment in these patients. Only one patient, who had the shortest disease duration (five months) in the whole group, showed a sustained benefit. We speculate that those patients with a shorter history, with presumably less demye-lination and more inflammatory lesions, would show a better response to immunossupressive treatments.<br>A mielopatia associada ao protovírus T-linfotrópico humano (HTLV-I), também conhecida como paraparesia espástica tropical associada ao HTLV-I (MAH/PET), constitui enfermidade imunomediada desencadeada pela infecção pelo HTLV-I. Nesta condição tem sido demonstrada, particularmente em pacientes japoneses, boa resposta clínica à terapêutica com corticosteróides. Este efeito benéfico todavia não foi encontrado em todas as regiões do mundo. Pulsoterapia com metilprednisolona endovenosa tem sido utilizada com sucesso em pacientes com esclerose múltipla, outro exemplo de doença auto-imune do sistema nervoso central, especialmente durante as fases de exacerbação da doença. Objetivando testar a eficácia da pulsoterapia com metilprednisolona em pacientes com MAH/PET, conduzimos estudo aberto em 23 doentes. Não constatamos efeito benéfico significativo desta forma de tratamento na maioria dos enfermos estudados. Apenas um dos pacientes, o qual exibia o menor tempo de duração de doença (cinco meses), obteve benefício a longo prazo. Acreditamos que tratamentos imunossupressivos devam ser de maior utilidade naqueles doentes com menor tempo de evolução, nos quais, possivelmente, há preponderância do processo inflamatório sobre o desmielinizante.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X1993000300005HTLV-Iparaparesia espástica tropicalmetilprednisolonaHTLV-Itropical spastic paraparesismethylprednisolone |
| spellingShingle | Abelardo Q-C Araújo Cristiane R. Afonso Ana Claudia B. Leite Solange V. Dultra Intravenous methylprednisolone in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) Metilprednisolona endovenosa na mielopatia associada ao HTLV-I/Paraparesia Espástica Tropical (MAH/PET) Arquivos de Neuro-Psiquiatria HTLV-I paraparesia espástica tropical metilprednisolona HTLV-I tropical spastic paraparesis methylprednisolone |
| title | Intravenous methylprednisolone in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) Metilprednisolona endovenosa na mielopatia associada ao HTLV-I/Paraparesia Espástica Tropical (MAH/PET) |
| title_full | Intravenous methylprednisolone in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) Metilprednisolona endovenosa na mielopatia associada ao HTLV-I/Paraparesia Espástica Tropical (MAH/PET) |
| title_fullStr | Intravenous methylprednisolone in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) Metilprednisolona endovenosa na mielopatia associada ao HTLV-I/Paraparesia Espástica Tropical (MAH/PET) |
| title_full_unstemmed | Intravenous methylprednisolone in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) Metilprednisolona endovenosa na mielopatia associada ao HTLV-I/Paraparesia Espástica Tropical (MAH/PET) |
| title_short | Intravenous methylprednisolone in HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) Metilprednisolona endovenosa na mielopatia associada ao HTLV-I/Paraparesia Espástica Tropical (MAH/PET) |
| title_sort | intravenous methylprednisolone in htlv i associated myelopathy tropical spastic paraparesis ham tsp metilprednisolona endovenosa na mielopatia associada ao htlv i paraparesia espastica tropical mah pet |
| topic | HTLV-I paraparesia espástica tropical metilprednisolona HTLV-I tropical spastic paraparesis methylprednisolone |
| url | http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0004-282X1993000300005 |
| work_keys_str_mv | AT abelardoqcaraujo intravenousmethylprednisoloneinhtlviassociatedmyelopathytropicalspasticparaparesishamtspmetilprednisolonaendovenosanamielopatiaassociadaaohtlviparaparesiaespasticatropicalmahpet AT cristianerafonso intravenousmethylprednisoloneinhtlviassociatedmyelopathytropicalspasticparaparesishamtspmetilprednisolonaendovenosanamielopatiaassociadaaohtlviparaparesiaespasticatropicalmahpet AT anaclaudiableite intravenousmethylprednisoloneinhtlviassociatedmyelopathytropicalspasticparaparesishamtspmetilprednisolonaendovenosanamielopatiaassociadaaohtlviparaparesiaespasticatropicalmahpet AT solangevdultra intravenousmethylprednisoloneinhtlviassociatedmyelopathytropicalspasticparaparesishamtspmetilprednisolonaendovenosanamielopatiaassociadaaohtlviparaparesiaespasticatropicalmahpet |